Join to View Full Profile
505 E 70th St2nd FloorNew York, NY 10021
Phone+1 212-746-1562
Fax+1 212-746-8439
Dr. Silberzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Silberzweig, based in New York, NY, is a nephrologist with expertise in general nephrology and specific conditions such as acute renal failure, chronic kidney disease, acute interstitial nephritis, and chronic renal failure. He completed his medical education at the University at Buffalo, followed by a residency in internal medicine and a fellowship in nephrology. Dr. Silberzweig has several publications in reputable journals, focusing on topics like dialysis and patient care outcomes. He has also been involved in clinical trials related to care decision-making and dialysis-related conditions. Dr. Silberzweig received a CMS Meaningful Use Stage 1 Certification for his use of electronic health records.
Education & Training
University of Pennsylvania Health SystemFellowship, Nephrology, 1992 - 1994
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1989 - 1992
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1989
Certifications & Licensure
NY State Medical License 1991 - 2026
FL State Medical License 2012 - 2019
PA State Medical License 1991 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2015-2016
Clinical Trials
- Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
- Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease. Start of enrollment: 2018 Dec 26
- Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial Start of enrollment: 2024 Nov 13
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- ADominant Nasal Microbiota in Hemodialysis Patients.Sylvia Wu, Nicholas Tedrow, Abhinav Bhalla, Alex Devito, Sheavonnie Wright
Kidney Medicine. 2025-10-01 - Quality Metrics in Dialysis: It Takes a Village.Abhinav Bhalla, Sri Lekha Tummalapalli, Jeffrey Silberzweig
Advances in Kidney Disease and Health. 2025-09-01 - 3 citationsClinical Outcomes of a Novel Multidisciplinary Care Program in Advanced Kidney Disease (PEAK).Daniil Shimonov, Sri Lekha Tummalapalli, Stephanie Donahue, Vidya Narayana, Sylvia Wu
Kidney International Reports. 2024-10-01
Press Mentions
Regular SARS-CoV-2 Testing in Hemodialysis Facilities Unacceptable to Most PatientsOctober 1st, 2024- Q&A: Nephrologists Offer Next Steps in Addressing the COVID-19 Omicron VariantDecember 27th, 2021
- Fauci, ASN Panelists Encourage Patients with CKD to Get COVID-19 Booster VaccineNovember 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
